Reunion Biotech

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of medical hydrogel products intended to provide new medical solutions. Reunion Biotech is based in Shanghai, China and was founded in 2018. Its last reported valuation was $45.1 million in Dec 2021. It has raised $35.4 million.

Last reported valuation
$45.1M
Oct 2026
Priced at
—
Total raised
$35.4M
Last round
—

Who backs Reunion Biotech?

10 investors
InvestorType
Qiming Venture PartnersVenture capital
Proxima Ventures (China)Venture capital
Yunfeng CapitalPE / buyout
Qingdao Conson Financial HoldingsOther
Dingxin Capital—
Fudan Science and Technology Innovation—
Fudan University—
Jiaxing Deshi Private Equity Fund Management—
TigerYeah Capital—
Yushan Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Reunion Biotech investors

10 investors are on record for Reunion Biotech, including Qiming Venture Partners, Proxima Ventures (China), Yunfeng Capital and Qingdao Conson Financial Holdings.

Free account
More of Reunion Biotech with a free account
  • ·Watch Reunion Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Reunion Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View